[CMSB] QoQ Annualized Quarter Result on 30-Sep-2023 [#3]

Stock
[CMSB] CAHYA MATA SARAWAK BHD
Announcement Date
29-Nov-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2023
Quarter
30-Sep-2023 [#3]
Profit Trend
QoQ- -23.68%
YoY- -70.34%
Quarter Report
Latest QR
Upcoming QR
CMSB's Result
CMSB's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 1,110,712 1,109,484 1,200,744 1,157,456 1,132,380 1,102,668 1,008,968 6.62%
PBT 215,100 229,020 129,223 131,044 149,180 157,052 412,301 -35.21%
Tax -73,552 -70,904 -46,678 -52,536 -41,098 -47,708 -110,715 -23.88%
NP 141,548 158,116 82,545 78,508 108,082 109,344 301,586 -39.63%
-
NP to SH 143,220 152,980 115,130 105,178 137,806 170,232 298,060 -38.67%
-
Tax Rate 34.19% 30.96% 36.12% 40.09% 27.55% 30.38% 26.85% -
Total Cost 969,164 951,368 1,118,199 1,078,948 1,024,298 993,324 707,382 23.38%
-
Net Worth 3,394,396 3,372,912 3,297,720 3,211,786 3,201,044 3,233,269 3,233,871 3.28%
Dividend
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Div 42,967 - 21,483 42,967 64,450 128,901 32,231 21.14%
Div Payout % 30.00% - 18.66% 40.85% 46.77% 75.72% 10.81% -
Equity
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Net Worth 3,394,396 3,372,912 3,297,720 3,211,786 3,201,044 3,233,269 3,233,871 3.28%
NOSH 1,074,376 1,074,376 1,074,376 1,074,376 1,074,376 1,074,376 1,074,376 0.00%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 12.74% 14.25% 6.87% 6.78% 9.54% 9.92% 29.89% -
ROE 4.22% 4.54% 3.49% 3.27% 4.31% 5.27% 9.22% -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
RPS 103.40 103.29 111.78 107.75 105.42 102.65 93.91 6.63%
EPS 13.34 14.24 10.72 9.79 12.82 15.84 27.75 -38.66%
DPS 4.00 0.00 2.00 4.00 6.00 12.00 3.00 21.16%
NAPS 3.16 3.14 3.07 2.99 2.98 3.01 3.01 3.29%
Adjusted Per Share Value based on latest NOSH - 1,074,376
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
RPS 103.34 103.23 111.72 107.69 105.36 102.59 93.87 6.62%
EPS 13.33 14.23 10.71 9.79 12.82 15.84 27.73 -38.66%
DPS 4.00 0.00 2.00 4.00 6.00 11.99 3.00 21.16%
NAPS 3.1581 3.1381 3.0682 2.9882 2.9782 3.0082 3.0088 3.28%
Price Multiplier on Financial Quarter End Date
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Date 28/06/24 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 30/12/22 -
Price 1.39 0.93 1.08 1.14 0.955 1.14 1.07 -
P/RPS 1.34 0.90 0.97 1.06 0.91 1.11 1.14 11.38%
P/EPS 10.43 6.53 10.08 11.64 7.44 7.19 3.86 94.11%
EY 9.59 15.31 9.92 8.59 13.43 13.90 25.93 -48.50%
DY 2.88 0.00 1.85 3.51 6.28 10.53 2.80 1.89%
P/NAPS 0.44 0.30 0.35 0.38 0.32 0.38 0.36 14.32%
Price Multiplier on Announcement Date
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Date 27/08/24 23/05/24 26/02/24 29/11/23 30/08/23 22/05/23 27/02/23 -
Price 1.30 1.19 0.975 1.11 1.17 1.14 1.34 -
P/RPS 1.26 1.15 0.87 1.03 1.11 1.11 1.43 -8.09%
P/EPS 9.75 8.36 9.10 11.34 9.12 7.19 4.83 59.79%
EY 10.26 11.97 10.99 8.82 10.96 13.90 20.70 -37.39%
DY 3.08 0.00 2.05 3.60 5.13 10.53 2.24 23.67%
P/NAPS 0.41 0.38 0.32 0.37 0.39 0.38 0.45 -6.02%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment